This opportunity is no longer accepting applications.
grant FDA-CDER-2026-0034

FDA research fellowship: serum creatinine increases from renal-transporter inhibition in oncology drugs

Paid research fellowship at FDA CDER (Silver Spring, MD) to study pharmacokinetic interactions and risk-mitigation for serum creatinine elevations caused by inhibition of renal transporters (OCT2, MATE1, MATE2‑K) in approved oncology drugs. Work includes data curation, clinical dataset analysis, PK/PD modeling, and contributions to labeling and regulatory guidance; administered through ORAU/OR…

FDA Office and Location: A research opportunity is available in the Office of Translational Sciences (OTS) at the Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), located in Silver Spring, Maryland.

The Center for Drug Evaluation and Res…

Funding Source

Agency: U.S. Food and Drug Administration

Eligibility

Qualifications

The qualified candidate should have received a bachelor's, master's, or doctoral degree in one of the relevant fields. Degree must have been received within the past five years.

Eligibility Requirements

  • Citizensh…

Dates

Application Deadline: May 14, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.